Atlas Trials

Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

Clinical trial NCT03633630 · COMPLETED

Trial details

NCT number
NCT03633630
Sponsor
University of Guadalajara
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Metabolic Syndrome
Start date
2019-04-01
Primary completion
2021-10-30
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.